Vanio Mitev Selected Research

Vanio Mitev Research Topics

Disease

7	Prostatic Neoplasms (Prostate Cancer) 01/2018 - 04/2013
6	Neoplasms (Cancer) 10/2018 - 09/2005
5	Dermatomyositis (Dermatopolymyositis) 08/2016 - 01/2012
3	Infections 12/2020 - 09/2002
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 08/2016 - 01/2013
3	Autoimmune Diseases (Autoimmune Disease) 01/2013 - 01/2012
2	Plasmacytoma 01/2004 - 04/2002
1	Ciliopathies 03/2024
1	Kidney Diseases (Kidney Disease) 03/2024
1	Glioblastoma (Glioblastoma Multiforme) 12/2020
1	Neoplasm Metastasis (Metastasis) 10/2018
1	Immune System Diseases (Immune Disorders) 12/2017
1	Cystic Kidney Diseases (Cystic Kidney Disease) 06/2017
1	Cough 05/2017
1	Epilepsy (Aura) 05/2017
1	Essential Hypertension 12/2015
1	Hemorrhage 12/2015
1	Coronary Artery Disease (Coronary Atherosclerosis) 12/2015
1	Myocardial Infarction 12/2015
1	Hypoxia (Hypoxemia) 06/2015
1	Carcinoma (Carcinomatosis) 06/2015
1	Cardiovascular Diseases (Cardiovascular Disease) 06/2015
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 03/2015
1	Parkinson Disease (Parkinson's Disease) 11/2014
1	Hyperhomocysteinemia 07/2014
1	Gestational Diabetes (Gestational Diabetes Mellitus) 04/2014
1	Bipolar Disorder (Manic Depressive Psychosis) 06/2013
1	Muscle Weakness 01/2013
1	Muscular Diseases (Myopathy) 01/2013
1	Colorectal Neoplasms (Colorectal Cancer) 04/2007
1	Microsatellite Instability 04/2007

Drug/Important Bio-Agent (IBA)

3	Genetic Markers (Genetic Marker)IBA 01/2018 - 09/2015
3	Interleukin-6 (Interleukin 6)IBA 01/2013 - 04/2002
2	DNA (Deoxyribonucleic Acid)IBA 12/2020 - 04/2013
2	Prostate-Specific Antigen (Semenogelase)IBA 10/2018 - 03/2015
2	AcenocoumarolIBA 12/2015 - 06/2015
2	Protein Isoforms (Isoforms)IBA 06/2015 - 01/2014
2	Estrogen ReceptorsIBA 07/2014 - 04/2007
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2012 - 01/2012
2	Mitogen-Activated Protein Kinase 1 (p42 MAP Kinase)IBA 12/2004 - 09/2002
1	SolutionsIBA 03/2024
1	ElectrolytesIBA 03/2024
1	antiglomerular basement membrane antibodyIBA 12/2020
1	AntigensIBA 12/2020
1	Antinuclear AntibodiesIBA 12/2017
1	Transcription Factors (Transcription Factor)IBA 06/2017
1	Calcitriol Receptors (Calcitriol Receptor)IBA 08/2016
1	AndrogensIBA 04/2016
1	Aromatase (CYP19)IBA 04/2016
1	Hormones (Hormone)IBA 01/2016
1	Death Domain ReceptorsIBA 01/2016
1	Cytochrome P-450 CYP2C8IBA 12/2015
1	AnticoagulantsIBA 12/2015
1	Cytochrome P-450 CYP2J2 (CYP2J2)IBA 12/2015
1	RNA (Ribonucleic Acid)IBA 06/2015
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2015
1	Biomarkers (Surrogate Marker)IBA 03/2015
1	Apolipoproteins E (ApoE)IBA 11/2014
1	ApolipoproteinsIBA 11/2014
1	PolyaminesIBA 07/2014
1	AdiponectinIBA 04/2014
1	CytokinesIBA 01/2014
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2014
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 06/2013
1	EnzymesIBA 01/2013
1	tocilizumab (atlizumab)FDA Link 01/2013
1	Interleukin-10 (Interleukin 10)IBA 01/2012
1	ErbB Receptors (EGF Receptor)IBA 07/2009
1	Vitamin D FDA LinkGeneric 04/2007
1	Cholecalciferol (Vitamin D3)FDA Link 04/2007
1	Estrogens (Estrogen)FDA Link 04/2007
1	RoscovitineIBA 09/2005
1	Differentiation AntigensIBA 09/2005
1	p38 Mitogen-Activated Protein KinasesIBA 09/2005
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 09/2005
1	LipopolysaccharidesIBA 01/2004
1	KN 62IBA 09/2002
1	MAP Kinase Kinase 1IBA 09/2002
1	U 0126 (UO 126)IBA 09/2002
1	2- (1- (3- dimethylaminopropyl)- 5- methoxyindol- 3- yl)- 3- (1H- indol- 3- yl)maleimideIBA 04/2002
1	Mitogen-Activated Protein KinasesIBA 04/2002

Therapy/Procedure

2	Therapeutics 12/2020 - 12/2015
1	Traditional Medicine (Folk Remedies) 05/2017
1	Estrogen Replacement Therapy 04/2007